Cross-linked HA skin boosters contain hyaluronic acid chemically bonded into a gel that resists enzymatic breakdown for longer, while non-cross-linked HA is a thin, fast-degrading liquid that spreads smoothly through the dermis. Choosing between cross-linked vs non-cross-linked hyaluronic acid skin boosters depends on treatment goals, the area treated and the product's rheology, not on one type being universally superior.
Key Takeaways
- Cross-linking links HA chains together, changing a liquid into a gel and prolonging its persistence in tissue.
- Non-cross-linked HA is typically used for smooth, even hydration; it is degraded quickly, so protocols usually involve a series of sessions.
- Published clinical data on both types are largely small, single-centre and often manufacturer-funded; no robust head-to-head trial was identified in our research.
- Technique, depth and volume strongly influence outcomes and the risk of papules; results vary between patients.
- Distributors and clinics should verify authenticity, documentation and local regulatory status for every HA product they stock.
What Is the Difference Between Cross-Linked and Non-Cross-Linked HA?
The difference is chemical structure. Cross-linking creates bonds between hyaluronic acid molecules, turning a liquid into a gel and extending its lifespan in tissue; non-cross-linked HA stays liquid and is broken down much faster.
Hyaluronic acid (HA) is a naturally occurring glycosaminoglycan found in the dermis, where it binds water. Injectable products use HA of non-animal origin, produced by bacterial fermentation. In a clinician commentary published by IMCAS, Prof. Yan Wu describes non-cross-linked HA as having a half-life in skin of under 24 hours, whereas cross-linking extends persistence and changes the material from liquid to gel. Note that this is an expert commentary rather than a controlled study.
The Cureus 2025 study of a non-cross-linked HA device (Foliage Hydrofil, 32 mg of non-cross-linked HA per 2 mL vial with molecular weights of 200, 500 and 1000 kDa) states that cross-linked, hyaluronidase-resistant HA is widely used in dermal fillers for volume and contour, while non-cross-linked HA is used as a biorevitalization component to improve hydration. The authors did not test degradation of either form.
| Feature | Non-cross-linked HA | Cross-linked / low-cross-linked HA |
|---|---|---|
| Physical form | Fluid, spreads easily in the dermis | Gel with varying degrees of cohesivity |
| Reported persistence | Short; half-life described as under 24 hours (expert commentary) | Longer; varies by product and degree of cross-linking |
| Typical aim | Hydration and smoother skin appearance | Hydration, elasticity and structural support |
| Typical session pattern in studies | Series of sessions (three, about three weeks apart, in the Cureus study) | Series of sessions (monthly for three months in the ASJ Open Forum study) |
| Technique considerations | Intradermal micropapules or microdroplets per manufacturer guidance | Care with depth and volume to reduce visible papules |
What Does Clinical Evidence Say About Non-Cross-Linked HA Skin Boosters?
Small studies report improved skin hydration after a short series of injections, but they are mostly uncontrolled and limited in follow-up. The evidence supports use for hydration rather than dramatic change in wrinkles.
The 2025 Cureus post-marketing study (Chahine et al.) enrolled 24 adults, mean age 44.0, with mild-to-moderate facial photoaging. Participants received three intradermal injections at roughly three-week intervals. Mean skin capacitance rose from 23.1 to 33.2 a.u. (p = 0.001), and no adverse events were documented. However, the study was single-arm and open-label, follow-up was short, investigator-rated wrinkle improvement was negligible, and the study was funded by the product's manufacturer. The authors themselves call for larger randomized trials.
What Does Evidence Show for Cross-Linked HA Skin Boosters?
Evidence from a small randomized split-face study suggests that dose matters: a higher total dose of a low-cross-linked HA gel produced more durable improvement than a lower dose.
The 2025 Aesthetic Surgery Journal Open Forum study (Wang et al., Ruijin Hospital, Shanghai) enrolled 30 women aged 28 to 55. Each received three monthly intradermal sessions, with 24 mg (about 2 mL) on one side of the face and 48 mg (about 4 mL) on the other. The high-dose side showed improvement in photoaging scores at all time points through six months, whereas the low-dose side was no longer significantly improved at six months. Bruising and erythema occurred in 23.3% of participants and resolved within two days. Limitations include the single centre, two doses only, six-month follow-up and manufacturer funding of the product tested. These findings apply to that specific gel and cannot be extended to all cross-linked products.
The IMCAS commentary also reports that, in its author's observations, only cross-linked HA increased stratum corneum water content, peaking at four weeks, with no significant TEWL change. Again, this is a short commentary without full methods.
How Do Practitioners Choose Between the Two Types?
Practitioners generally choose based on the treatment goal, the treatment area and the product's documented rheology and instructions for use. Both types are usually injected into the dermis, not deeper.
Factors commonly considered
- Treatment goal: hydration and smooth texture versus longer-lasting elasticity support.
- Area: thin, delicate zones call for fluid, low-viscosity products and conservative volumes.
- Patient factors: skin thickness, prior treatments, expectations and healing history.
- Combination planning: HA boosters are sometimes combined with polynucleotide or PDRN-based boosters or collagen stimulators in staged protocols, always according to each product's instructions.
For related science, see our explainer on PN vs PDRN skin boosters, our comparison of PLLA, PCL and PDLLA collagen stimulators and our guide to Korean skin boosters.
What Safety Considerations Apply to HA Skin Boosters?
Common effects are transient bruising, erythema and swelling; visible papules and, rarely, more serious complications are possible. Only trained practitioners should treat, with complication protocols available.
Because both HA types are injected intradermally in multiple points, hygiene, correct depth and volume discipline are essential. HA products can generally be degraded with hyaluronidase, but practitioners should confirm this against the specific product's labelling. Our guide to HA filler vascular occlusion prevention covers complication management for HA products in more depth.
What Should Clinics and Distributors Check Before Sourcing HA Skin Boosters?
Verify the manufacturer, batch documentation, storage conditions and the regulatory status in your own market before ordering any injectable.
- Request manufacturer identification, composition (HA concentration, cross-linking description) and instructions for use.
- Confirm regulatory clearance or registration in your destination country; do not assume it from another market.
- Ensure cold-chain or temperature requirements stated on the label are respected in transit and storage.
- Use our authenticity checklist approach as a model for documentation checks.
HolyPath Aesthetic supplies Korean aesthetic products to professionals, including Vijubelle cross-linked HA, Volizer cross-linked HA and Rejuran HB (PN + HA). Product specifications should be requested directly and checked against official documentation.
Frequently Asked Questions
Is cross-linked or non-cross-linked HA better for skin boosters?
Neither is universally better. Published evidence does not include a robust head-to-head trial of the two types, so the choice depends on the treatment goal, area, product rheology and practitioner technique. Cross-linked gels are generally positioned for longer-lasting effects, non-cross-linked HA for smooth, immediate hydration. Always follow each manufacturer's instructions for use.
How long does non-cross-linked HA last in the skin?
Non-cross-linked HA is degraded quickly. An IMCAS clinician commentary describes its half-life in skin as under 24 hours, although this is an expert opinion rather than a controlled trial. Clinical benefit reported in studies reflects repeated sessions, so protocols typically involve a series of treatments rather than a single injection.
Can cross-linked skin boosters cause visible lumps?
Visible papules or nodules can occur with any intradermal gel, particularly when too much product is placed too superficially. Technique, product choice and injected volume matter. Practitioners should follow the manufacturer's instructions, use appropriate depth and volume, and be trained to manage complications.
Does a higher dose of cross-linked HA improve results?
In one 30-participant split-face study of a low-cross-linked HA gel, the 48 mg side outperformed the 24 mg side at every follow-up through six months. The authors note limitations, including a single centre, two doses only and manufacturer funding, so results cannot be generalised to every product.
Are skin boosters the same as dermal fillers?
No. Skin boosters are injected into the dermis mainly to improve hydration, elasticity and skin quality, while dermal fillers are generally placed deeper to restore volume or contour. The categories overlap in chemistry, since both can be HA-based, but intended use, rheology and injection technique differ.
Conclusion
Cross-linked and non-cross-linked HA skin boosters serve overlapping but different purposes, and the current evidence base is modest and often manufacturer-funded. Clinics and distributors should evaluate each product on its own documentation. To discuss sourcing, send a B2B inquiry to HolyPath.
References
- Chahine S, et al. Efficacy and Safety of Non-cross-Linked Hyaluronic Acid Injections for Facial Skin Biorevitalization. Cureus. 2025. PMC12431166
- Wang S, et al. Dose-Dependent Effects of Cross-Linked Hyaluronic Acid Through Intradermal Injection on Female Facial Photoaging. Aesthetic Surgery Journal Open Forum. 2025. PMC12212054
- Wu Y. Droplets HA injection in dermis. IMCAS blog, 2016. imcas.com
This article is for informational purposes for licensed medical professionals and distributors. It is not medical advice. Treatments should be performed only by qualified practitioners in accordance with local regulations.